- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 89,400 | 27.05.24 14:38:18 | +0,100 | +0,11% | 89,360 | 89,400 | 89,290 | 89,300 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 904,600 | 27.05.24 09:15:33 | -6,200 | -0,68% | 904,600 | 910,600 | 910,800 | 910,800 |
